Following a recommendation by the Panamerican Health Organization, local medical authorities are instructing pharmacies to discontinue sales of the following drugs, most cold medicine or appetite suppressors, containing phenylpropanolamine (PPA) that is considered damaging secondary effects: Achoo, Alivium, Antifludes, Babyrhinol Lepetit, Bonabron-D, Ciricidin-D, Coritussal, Delgazin, Descongel, Desenfriolito, Docefal, Fluvin, Gripocap, Mucorama TS, Multitab, Nasomixin, Rhinopront, Adelgadina, Broncochem, Comtrex, Contac, Decidex, Desenfriol, Desenfriolito, Diametapp, Duadacin, Gutiberna, Mapsesil, Mocox, Pectusin, Phentabs, Sinutab, Triaminic B1. An official from Warner Lambert that distributes Sinutad denied that the medicine contained PPA, and said that the initial list is not the definitive official list. For more information on PPA, see http://www.msnbc.com/news/485293.asp#BODY http://www.msnbc.com/news/486786.asp#BODY
